GoAI
Get started
CUC Inc. logo

CUC Inc.

9158.T

JPXHealthcareMedical - Care Facilities

Open in GoAI

Latest quote

¥724

−¥5.00 · -0.69%

Aug 24, 11:14 AM JST

9158.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

CUC Inc. delivers a diverse range of healthcare provisions across Japan, throughout Asia, and globally. Their services cover critical areas like inpatient hospital care, specialized dialysis treatments, visiting nurse programs, and home hospice support. Beyond direct patient care, the company also offers essential management assistance to healthcare organizations and provides expert healthcare consulting. Founded in 2014, CUC Inc. is headquartered in Minato-Ku, Japan, and operates as an affiliate of M3 Inc.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
JP
CEO
Keita Hamaguchi
Listed since
Jun 21, 2023
Employees
5,740

Market position

Day range

Current ¥724

52-week range

Current ¥724

Open
¥730
Previous close
¥729
Volume
20.9K
0.16× average
Average volume
132.56K
Average daily volume
Market cap
21.22B JPY
Beta
1.21
Market reference 1
50-day average
¥787.2
-8.03% below average
200-day average
¥865.3
-16.33% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM)
8.97×
P/B (TTM)
0.63×
P/S (TTM)
0.38×
Dividend yield
0.00%

Profitability & efficiency

Gross margin
46.35%
Operating margin
5.17%
Net margin
4.26%

Financial health

Debt / equity
1.7×
Altman Z-score
1.27
Piotroski F-score
4 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends51%34%18%1%Gross margin, FY2021: 37.32%Gross margin, FY2022: 35.66%Gross margin, FY2023: 42.75%Gross margin, FY2024: 42.30%Gross margin, FY2025: 46.76%Operating margin, FY2021: 15.46%Operating margin, FY2022: 10.53%Operating margin, FY2023: 11.26%Operating margin, FY2024: 10.19%Operating margin, FY2025: 6.66%Net margin, FY2021: 7.67%Net margin, FY2022: 6.88%Net margin, FY2023: 7.86%Net margin, FY2024: 6.66%Net margin, FY2025: 5.25%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 37.32%. Gross margin FY2022 35.66%. Gross margin FY2023 42.75%. Gross margin FY2024 42.30%. Gross margin FY2025 46.76%. Operating margin FY2021 15.46%. Operating margin FY2022 10.53%. Operating margin FY2023 11.26%. Operating margin FY2024 10.19%. Operating margin FY2025 6.66%. Net margin FY2021 7.67%. Net margin FY2022 6.88%. Net margin FY2023 7.86%. Net margin FY2024 6.66%. Net margin FY2025 5.25%.

Income trends

Revenue

54.35B JPY+15.54%

Operating income

3.62B JPY-24.51%

Net income

2.85B JPY-8.85%
Income trends across reported periods59.55B JPY38.77B JPY18B JPY−2.77B JPYRevenue, FY2021: 35.31B JPYRevenue, FY2022: 35.21B JPYRevenue, FY2023: 33.03B JPYRevenue, FY2024: 47.04B JPYRevenue, FY2025: 54.35B JPYOperating income, FY2021: 5.46B JPYOperating income, FY2022: 3.71B JPYOperating income, FY2023: 3.72B JPYOperating income, FY2024: 4.79B JPYOperating income, FY2025: 3.62B JPYNet income, FY2021: 2.71B JPYNet income, FY2022: 2.42B JPYNet income, FY2023: 2.6B JPYNet income, FY2024: 3.13B JPYNet income, FY2025: 2.85B JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 35.31B JPY. Revenue FY2022 35.21B JPY. Revenue FY2023 33.03B JPY. Revenue FY2024 47.04B JPY. Revenue FY2025 54.35B JPY. Operating income FY2021 5.46B JPY. Operating income FY2022 3.71B JPY. Operating income FY2023 3.72B JPY. Operating income FY2024 4.79B JPY. Operating income FY2025 3.62B JPY. Net income FY2021 2.71B JPY. Net income FY2022 2.42B JPY. Net income FY2023 2.6B JPY. Net income FY2024 3.13B JPY. Net income FY2025 2.85B JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue54.35B JPY47.04B JPY33.03B JPY35.21B JPY35.31B JPY
Cost of goods sold28.94B JPY27.14B JPY18.91B JPY22.66B JPY22.14B JPY
Gross profit25.41B JPY19.9B JPY14.12B JPY12.56B JPY13.18B JPY
Selling, general, and administrative21.8B JPY14.34B JPY9.83B JPY8.3B JPY7.37B JPY
Operating expenses21.8B JPY15.11B JPY10.4B JPY8.85B JPY7.72B JPY
Interest income62M JPY24M JPY28M JPY50M JPY31M JPY
Interest expense735M JPY510M JPY284M JPY93M JPY100M JPY
Depreciation and amortization4.9B JPY3.29B JPY1.81B JPY1.22B JPY1.07B JPY
Operating income3.62B JPY4.79B JPY3.72B JPY3.71B JPY5.46B JPY
Net income2.85B JPY3.13B JPY2.6B JPY2.42B JPY2.71B JPY

Company facts updated Aug 24, 2026.

9158.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥7,008

-0.04%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,799

+0.61%

HOYA Corporation logo

7741.T

HOYA Corporation

¥24,990

+0.38%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,205

+0.08%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,862

+1.01%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,392.5

+0.23%

ETFs holding 9158.T

Funds reporting this stock among their holdings, ordered by reported position size.

Avantis International Small Cap Value ETF logoAvantis International Small Cap Value ETFAVDV
Market value
142.15K
Weight
—
AUM
20.24B USD
Expense ratio
0.36%
Price / 1D
$111.95+1.06%
Dimensional - International Small Cap Value ETF logoDimensional - International Small Cap Value ETFDISV
Market value
84.86K
Weight
0.00%
AUM
5.23B USD
Expense ratio
0.42%
Price / 1D
$44.49+0.86%
Dimensional - International Small Cap ETF logoDimensional - International Small Cap ETFDFIS
Market value
51.01K
Weight
0.00%
AUM
5.91B USD
Expense ratio
0.39%
Price / 1D
$37.545+0.71%
Dimensional - International Core Equity 2 ETF logoDimensional - International Core Equity 2 ETFDFIC
Market value
2.78K
Weight
0.00%
AUM
15.43B USD
Expense ratio
0.22%
Price / 1D
$39.405+0.83%
Avantis International Small Cap Equity ETF logoAvantis International Small Cap Equity ETFAVDS
Market value
2.3K
Weight
—
AUM
340.61M USD
Expense ratio
0.30%
Price / 1D
$80.49+0.93%

Continue in GoAI

Research 9158.T

research.disclaimer